danoprevir
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
As coronavirus disease 2019 (COVID-19) outbreak, caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2…
HCV serine protease NS3 represents an attractive drug target because it is not only essential for viral replication but also…
The current paradigm for studying hepatitis C virus (HCV) dynamics in patients utilizes a standard viral dynamic model that keeps…
Hepatitis C virus (HCV) infects over 170 million people worldwide and is the leading cause of chronic liver diseases, including…
BACKGROUND & AIMS
Although interleukin 28B (interferon, lambda 3) (IL28B) genotype affects the response of patients with chronic…
ABSTRACT In the INFORM-1 study, 73 patients with chronic hepatitis C virus infection received mericitabine plus danoprevir for up…
Protease inhibitors (PIs) have proven to be effective adjuncts to interferon/ribavirin treatment of hepatitis C virus (HCV…
ABSTRACT Danoprevir is a hepatitis C virus (HCV) NS3/4A protease inhibitor that promotes multi-log10 reductions in HCV RNA when…
Background/aim Insulin resistance (IR) is a major predictor of treatment failure in patients with hepatitis C virus (HCV…